CVR: 46672909
Not available
Tetra Pharm Technologies ApS
CVR · view ownership and management
Name registered: Tetrapharm Bioengineering ApS
CVR · 31/07/2026
View the full event history
Tetrapharm Bioengineering ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2026. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jesper Breum and Martin Stefan Rose. The company is owned by Tetra Pharm Technologies ApS.
Selskabets formål er at være biotekselskab, investering samt enhver beslægtet virksomhed efter ledelsens beslutning.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningTetrapharm Bioengineering ApS was founded on 31 July 2026.
Tetrapharm Bioengineering ApS is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
Tetrapharm Bioengineering ApS is owned by Tetra Pharm Technologies ApS.
The management of Tetrapharm Bioengineering ApS consists of Jesper Breum and Martin Stefan Rose.
Tetrapharm Bioengineering ApS is located at c/o Tetra Pharm, Ørestads Boulevard 108, 2300 København S.
The CVR number of Tetrapharm Bioengineering ApS is 46672909.
Claim this page to add your logo and social links. Free to get started.
As of July 31, 2026, MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Tetrapharm Bioengineering ApS.
As of July 31, 2026, Claus Berner Nielsen has joined the board of directors of Tetrapharm Bioengineering ApS.
As of July 31, 2026, Jesper Breum has joined the board of directors of Tetrapharm Bioengineering ApS.
As of July 31, 2026, Søren Maarssø has joined the board of directors of Tetrapharm Bioengineering ApS.
As of July 31, 2026, Rolf Sass Sørensen has joined the board of directors of Tetrapharm Bioengineering ApS.
As of July 31, 2026, Jesper Breum is registered as director of Tetrapharm Bioengineering ApS.
As of July 31, 2026, Martin Stefan Rose is registered as director of Tetrapharm Bioengineering ApS.
As of July 31, 2026, Tetra Pharm Technologies ApS is registered as an owner of Tetrapharm Bioengineering ApS with an ownership share of 100%.
Tetrapharm Bioengineering ApS was founded on July 31, 2026.
Companies in the same industry and area
CVR 40738223
CVR 46673034
CVR 41040351
CVR 26524938
CVR 42376558
